Pfizer Other Current Assets 2010-2024 | PFE

Pfizer other current assets for the quarter ending June 30, 2024 were $7.884B, a 1.72% decline year-over-year.

  • Pfizer other current assets for 2023 were $9.277B, a 7.95% increase from 2022.
  • Pfizer other current assets for 2022 were $8.594B, a 124.97% increase from 2021.
  • Pfizer other current assets for 2021 were $3.82B, a 4.77% increase from 2020.

Pfizer Other Current Assets 2010-2024 | PFE

  • Pfizer other current assets for 2023 were $9.277B, a 7.95% increase from 2022.
  • Pfizer other current assets for 2022 were $8.594B, a 124.97% increase from 2021.
  • Pfizer other current assets for 2021 were $3.82B, a 4.77% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B